[PDF][PDF] HOSPITALARIA
C González-Pérez, L Llorente-Sanz… - Farm Hosp, 2022 - sefh.es
Abstract Objective: The consolidation of Telepharmacy during the COVID-19 pandemic has
raised the need for managing large volumes of real-time activity data through data analysis …
raised the need for managing large volumes of real-time activity data through data analysis …
4CPS-316 Multiple sclerosis outpatient pharmaceutical care by an implanted telepharmacy tool during SARS-CoV-2 pandemic
CG Perez, AG Sacristan, ER Sanchez, JAP Pedrosa… - 2021 - ejhp.bmj.com
Background and importance The SARS-CoV-2 pandemic has highlighted the need to avoid
exposure of patients to places with a high probability of transmission, such as hospitals …
exposure of patients to places with a high probability of transmission, such as hospitals …
[HTML][HTML] Inteligencia empresarial para la visualización y análisis de datos de indicadores de actividad de Telefarmacia en un cuadro de mando de un servicio de …
C González-Pérez… - FARMACIA …, 2022 - revistafarmaciahospitalaria.sefh.es
Objetivo: La consolidación de la Telefarmacia en el contexto de la pandemia por la COVID-
19 exige manejar a tiempo real un gran volumen de datos de actividad mediante análisis de …
19 exige manejar a tiempo real un gran volumen de datos de actividad mediante análisis de …
CP-104 Role of statins added to interferon treatment in patients with relapsing-remitting multiple sclerosis: a meta-analysis
LL Esteban, ÁL Medina, BR Sastre, RV Sánchez… - 2015 - ejhp.bmj.com
Background Multiple sclerosis is a chronic inflammatory disorder of the central nervous
system. Statins have demonstrated anti-inflammatory and immunomodulatory properties in …
system. Statins have demonstrated anti-inflammatory and immunomodulatory properties in …
PKP-030 Appropriateness of an initial prefixed dose of vancomycin and risk factors for overdose
…, R Vázquez-Sánchez, B Reques, A Liras-Medina… - 2016 - ejhp.bmj.com
Background Initial intravenous dosing with vancomycin should be based on actual body
weight (ABW) and subsequent dose titration based on renal function and serum trough …
weight (ABW) and subsequent dose titration based on renal function and serum trough …
PP-026 The importance of auditing parenteral nutrition compounding process
AL Medina, M Moreno-García, ME Martínez-Núñez… - 2016 - ejhp.bmj.com
Background According to the American Society of Health System Pharmacists (ASHP) and
the American Society of Parenteral and Enteral Nutrition (ASPEN), the pharmacist is …
the American Society of Parenteral and Enteral Nutrition (ASPEN), the pharmacist is …
CP-056 Patient treatment satisfaction after switching to biweekly subcutaneous peginterferon beta 1a from intramuscular interferon beta 1a
AL Medina, JSR Ferrández, AS Pérez, JMM Sesmero… - 2017 - ejhp.bmj.com
Background Peginterferon beta-1a (PEGIFNβ-1a) is administered subcutaneously biweekly,
which is an advantage over other treatment schedules used in multiple sclerosis (MS) …
which is an advantage over other treatment schedules used in multiple sclerosis (MS) …
CP-093 Use of fampridine in multiple sclerosis patients
A Onteniente-González, C Martín-Blas, Á Liras-Medina… - 2015 - ejhp.bmj.com
Background Fampridine is a drug indicated to improve walking in adult patients with multiple
sclerosis (MS). Patients should be evaluated after two weeks and treatment should be …
sclerosis (MS). Patients should be evaluated after two weeks and treatment should be …
CP-179 Patients exceeding doxorubicin recommended cumulative dose
LL Esteban, AL Medina, RD Fernández, TM García - 2016 - ejhp.bmj.com
Background Cardiotoxicity is a known risk of anthracycline treatment. The probability of
developing impaired myocardial function is estimated to be 1–2% at a total cumulative dose …
developing impaired myocardial function is estimated to be 1–2% at a total cumulative dose …
PS-047 Results of an allergy detection programme over preoperative antibiotic prophylaxis
…, A Onteniente-Gonzalez, A Liras-Medina… - 2016 - ejhp.bmj.com
Background The objective of preoperative antibiotic prophylaxis (PAP) is to reduce the
incidence of postoperative wound infection. In our centre, the pharmacy service is actively …
incidence of postoperative wound infection. In our centre, the pharmacy service is actively …